• 1
    Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244265.
  • 2
    Wright TC, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004; 103: 304308.
  • 3
    Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002; 52: 342362.
  • 4
    Bioscience Division, Los Alamos National Laboratory, the Regents of the University of California. HPV sequence database: PV types and hosts [database online]. Available at: Accessed August 23, 2004.
  • 5
    Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer–burden and assessment of causality. J Natl Cancer Inst Monogr 2003; 31: 313.
  • 6
    Schiffman M, Kjaer SK. Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003; 31: 1419.
  • 7
    Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis–role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003; 31: 2028.
  • 8
    Palefsky JM, Holly EA. Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr 2003; 31: 4146.
  • 9
    American Cancer Society. Cancer facts and figures 2004. Atlanta, GA: American Cancer Society, Inc.; 2004.
  • 10
    Lawson HW, Lee NC, Thames SF, et al. Cervical cancer screening among low-income women: results of a national screening program, 1991–1995. Obstet Gynecol 1998; 92: 745752.
  • 11
    Chen F, Trapido EJ, Davis K. Differences in stage at presentation of breast and gynecologic cancers among whites, blacks, and Hispanics. Cancer 1994; 73: 28382842.
  • 12
    Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000; 132: 810819.
  • 13
    US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Washington, DC: U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion; 1996.
  • 14
    ACOG committee opinion. Recommendations on frequency of Pap test screening. Number 152–March 1995. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1995; 49: 210211.
  • 15
    Franco EL. Primary screening of cervical cancer with human papillomavirus tests. J Natl Cancer Inst Monogr 2003; 31: 8996.
  • 16
    Solomon D. Role of triage testing in cervical cancer screening. J Natl Cancer Inst Monogr 2003; 31: 97101.
  • 17
    Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst 2000; 92: 397402.
  • 18
    Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002; 287: 23822390.
  • 19
    Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 2000; 283: 8793.
  • 20
    Belinson J, Qiao YL, Pretorius R, et al. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001; 83: 439444.
  • 21
    Clavel C, Masure M, Bory JP, et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 2001; 84: 16161623.
  • 22
    Petry U, Menton S, Menton M, et al. Inclusion of HPV-testing for routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br J Cancer 2003; 88: 15701577.
  • 23
    Schneider A, Hoyer H, Lotz B, et al. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer 2000; 9: 2934.
  • 24
    Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev 2000; 9: 945951.
  • 25
    US Preventive Services Task Force. Guide to Clinical Preventive Services. 3rd ed. Washington, DC: U.S. Department of Health and Human Services; 2003.
  • 26
    American College of Obstetrics and Gynecology. Practice bulletin: clinical management guidelines for obstetrician-gynecologists: cervical cytology screening. Obstet Gynecol 2003; 102: 417427.
  • 27
    Wright TC, Jr., Cox JT, Massad LS, et al. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287: 21202129.
  • 28
    US Food and Drug Administration. FDA approves expanded use of HPV test. 2003. Available at: Accessed on June 1, 2004.
  • 29
    Smith McCune K, Mancuso V, Contant V, Jackson R. Management of women with atypical Papanicolaou tests of undetermined significance by board-certified gynecologists: discrepancies with published guidelines. Am J Obstet Gynecol 2001; 185: 551556.
  • 30
    Kaiser Family Foundation National Survey of Public Knowledge of HPV, the Human Papillomavirus. Available at: Accessed July 22, 2004.
  • 31
    Dell DL, Chen H, Ahmad F, Stewart DE. Knowledge about human papillomavirus among adolescents. Obstet Gynecol 2000; 96: 653656.
  • 32
    Baer H, Allen S, Braun L. Knowledge of human papillomavirus infection among young adult men and women: implications for health education and research. J Community Health 2000; 25: 6778.
  • 33
    Ramirez JE, Ramos DM, Clayton L, et al. Genital human papillomavirus infections: knowledge, perception of risk, and actual risk in a nonclinic population of young women. J Womens Health 1997; 6: 113121.
  • 34
    Yacobi E, Tennant C, Ferrante J, et al. University students' knowledge and awareness of HPV. Prev Med 1999; 28: 535541.
  • 35
    Gerhardt CA, Pong K, Kollar LM, et al. Adolescents' knowledge of human papillomavirus and cervical dysplasia. J Pediatr Adolesc Gynecol 2000; 13: 1520.
  • 36
    Pitts M, Clarke T. Human papillomavirus infections and risks of cervical cancer: what do women know? Health Educ Res 2002; 17: 706714.
  • 37
    Mays RM, Zimet GD, Winston Y, et al. Human papillomavirus, genital warts, Pap smears, and cervical cancer: knowledge and beliefs of adolescent and adult women. Health Care Women Int 2000; 21: 361374.
  • 38
    Philips Z, Johnson S, Avis M, Whynes DK. Human papillomavirus and the value of screening: young women's knowledge of cervical cancer. Health Educ Res 2003; 18: 318328.
  • 39
    Lerman C, Miller SM, Scarborough R, et al. Adverse psychologic consequences of positive cytologic cervical screening. Am J Obstet Gynecol 1991; 165: 658662.
  • 40
    Campion MJ, Brown, Jr, McCance DJ, et al. Psychosexual trauma of an abnormal cervical smear. Br J Obstet Gynaecol 1988; 95: 175181.
  • 41
    Basen-Engquist K, Pasket ED, Buzaglo J, et al. Cervical cancer. Cancer 2003; 98: 20092014.
  • 42
    Bell S, Porter M, Kitchener H, et al. Psychological response to cervical screening. Prev Med 1995; 24: 610616.
  • 43
    Mindel A. Psychological and psychosexual implications of herpes simplex virus infections. Scand J Infect Dis Suppl 1996; 100: 2732.
  • 44
    Duncan B, Hart G, Scalar A, Bigrigg A. Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: implications for screening. BMJ 2001; 322: 195199.
  • 45
    Clarke P, Ebel C, Catotti DN, Stewart S. The psychosocial impact of human papillomavirus infection: implications for health care providers. Int J STD AIDS 1996; 7: 197200.
  • 46
    Maw RD, Reitano M, Roy M. An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998; 9: 571578.
  • 47
    Reed BD, Ruffin MT, Gorenflo DW, Zazove P. The psychosexual impact of human papillomavirus cervical infections. J Fam Pract 1999; 48: 110116.
  • 48
    Gilbert LK, Alexander L, Grosshans JF, Jolley L. Answering frequently asked questions about HPV. Sex Transm Dis 2003; 30: 193194.
  • 49
    Anhang R, Wright TC, Jr., Smock L, Goldie SJ. Women's desired information about human papillomavirus. Cancer 2004; 100: 315320.
  • 50
    McCaffery K, Forrest S, Waller J, et al. Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK. Br J Cancer 2003; 88: 4246.
  • 51
    Blake DR, Weber B, Fletcher KE. Adolescent and Young Women's Misunderstanding of the Term “Pap Smear”. Paper presented at: Annual Meeting of the Society for Adolescent Medicine; March 19–22, 2003; Seattle, WA.
  • 52
    Marteau TM, Senior V, Sasieni P. Women's understanding of a “normal smear test result”: experimental questionnaire based study. BMJ 2001; 322: 526528.
  • 53
    Meissner HI, Potosky AL, Convissor R. How sources of health information relate to knowledge and use of cancer screening exams. J Community Health 1992; 17: 153165.
  • 54
    Johnson J. Cancer-Related Information Seeking. Creskill, NJ: Hamptom Press, Inc.; 1997.
  • 55
    James C, James N, Davies D, et al. Preferences for different sources of information about cancer. Patient Educ Couns. 1999; 37: 273282.
  • 56
    Anhang R, Stryker JE, Wright TC, Jr., Goldie SJ. News media coverage of human papillomavirus. Cancer 2004; 100: 308314.
  • 57
    Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 2002; 29: 725735.
  • 58
    Digene Corporation. Available at: Accessed July 22, 2004.
  • 59
    Laurance J. Extra test “could cut cervical cancers by 40%”. The Independent. February 21, 2001:9.
  • 60
    Digene Corporation. Survey results show women expect more information, coverage from healthcare industry. 2002, Digene Corporation. Available at: Accessed July 22, 2004.
  • 61
    President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Making Health Care Decisions: A Report on the Ethical and Legal Implications of Informed Consent in the Patient-Practitioner Relationship. Washington, DC: US Government Printing Office; 1982.
  • 62
    Whitney SN, McGuire AL, McCullough LB. A typology of shared decision making, informed consent, and simple consent. Ann Intern Med 2004; 140: 5459.
  • 63
    Braddock CH 3rd, Fihn SD, Levinson W, et al. How doctors and patients discuss routine clinical decisions. Informed decision making in the outpatient setting. J Gen Intern Med 1997; 12: 339345.
  • 64
    Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 1999; 49: 651661.
  • 65
    Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med 1997; 44: 681692.
  • 66
    Epstein RM, Alper BS, Quill TE. Communicating evidence for participatory decision making. JAMA 2004; 291: 23592366.
  • 67
    Monk BJ, Wiley DJ. Human papillomavirus infections: truth or consequences. Cancer 2004; 100: 225227.
  • 68
    Davis TC, Williams MV, Marin E, et al. Health literacy and cancer communication. CA Cancer J Clin 2002; 52: 134149.